CIENCIASMEDICASNEWS: Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study - eClinicalMedicine

sábado, 16 de julio de 2022

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study - eClinicalMedicine

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study - eClinicalMedicine

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)